US Bancorp’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $94.7M | Sell |
|
|||||
|
2025
Q1 | $98.3M | Sell |
|
|||||
|
2024
Q4 | $101M | Sell |
|
|||||
|
2024
Q3 | $94.1M | Sell |
|
|||||
|
2024
Q2 | $81.9M | Sell |
|
|||||
|
2024
Q1 | $102M | Sell |
|
|||||
|
2023
Q4 | $115M | Sell |
|
|||||
|
2023
Q3 | $110M | Sell |
|
|||||
|
2023
Q2 | $115M | Sell |
|
|||||
|
2023
Q1 | $130M | Sell |
|
|||||
|
2022
Q4 | $143M | Buy |
|
|||||
|
2022
Q3 | $96.3M | Buy |
|
|||||
|
2022
Q2 | $96.2M | Sell |
|
|||||
|
2022
Q1 | $94.4M | Sell |
|
|||||
|
2021
Q4 | $120M | Buy |
|
|||||
|
2021
Q3 | $115M | Buy |
|
|||||
|
2021
Q2 | $110M | Buy |
|
|||||
|
2021
Q1 | $101M | Buy |
|
|||||
|
2020
Q4 | $84.1M | Buy |
|
|||||
|
2020
Q3 | $85.9M | Sell |
|
|||||
|
2020
Q2 | $109M | Sell |
|
|||||
|
2020
Q1 | $107M | Buy |
|
|||||
|
2019
Q4 | $81.6M | Buy |
|
|||||
|
2019
Q3 | $78.8M | Buy |
|
|||||
|
2019
Q2 | $77.8M | Buy |
|
|||||
|
2019
Q1 | $69.5M | Buy |
|
|||||
|
2018
Q4 | $66.2M | Sell |
|
|||||
|
2018
Q3 | $84.4M | Sell |
|
|||||
|
2018
Q2 | $81.5M | Sell |
|
|||||
|
2018
Q1 | $88.3M | Buy |
|
|||||
|
2017
Q4 | $80.1M | Buy |
|
|||||
|
2017
Q3 | $87.9M | Buy |
|
|||||
|
2017
Q2 | $72.3M | Buy |
|
|||||
|
2017
Q1 | $59.6M | Sell |
|
|||||
|
2016
Q4 | $66.2M | Sell |
|
|||||
|
2016
Q3 | $77.1M | Sell |
|
|||||
|
2016
Q2 | $84.7M | Sell |
|
|||||
|
2016
Q1 | $95.2M | Sell |
|
|||||
|
2015
Q4 | $108M | Sell |
|
|||||
|
2015
Q3 | $107M | Sell |
|
|||||
|
2015
Q2 | $128M | Sell |
|
|||||
|
2015
Q1 | $109M | Buy |
|
|||||
|
2014
Q4 | $100M | Buy |
|
|||||
|
2014
Q3 | $110M | Buy |
|
|||||
|
2014
Q2 | $85.2M | Buy |
|
|||||
|
2014
Q1 | $68.6M | Buy |
|
|||||
|
2013
Q4 | $67.8M | Sell |
|
|||||
|
2013
Q3 | $57.4M | Buy |
|
|||||
|
2013
Q2 | $43.8M | Buy |
|